
AI maps how a new antibiotic targets gut bacteria
MIT CSAIL and McMaster researchers used a generative AI model to reveal how a narrow-spectrum antibiotic attacks disease-causing bacteria, speeding up a process that normally takes years.

MIT CSAIL and McMaster researchers used a generative AI model to reveal how a narrow-spectrum antibiotic attacks disease-causing bacteria, speeding up a process that normally takes years.

McGill University researchers have developed an artificial intelligence tool that can detect previously invisible disease markers inside single cells.

Scientists at the University of Liverpool have developed a new low-cost blood test that could make it easier to detect Alzheimer’s disease at an earlier stage—helping patients receive treatment and support sooner.

NEW YORK, Sept. 30, 2025 /PRNewswire/ — Aidoc, the global leader in clinical AI, today announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the company’s novel multi-triage solution that flags a wide array of life-threatening, time-sensitive medical conditions, all within a single workflow. Built on CARE™, the first clinical-grade foundation model in healthcare with FDA cleared solutions, and deployed through Aidoc’s aiOS™ platform, the solution is designed to help care teams attend to high–risk cases faster and more consistently across the health system.

Penn researchers have developed an AI-powered device that turns ordinary glasses into a smart, energy-efficient health monitor by watching you blink.

An advanced AI tool can detect tiny brain lesions that cause severe epilepsy in children, allowing faster diagnosis, more precise treatment and a potential cure, according to a new study.

Olympus announced today that it launched its Olysense platform with Caddie medical device software for early colorectal polyp detection.

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments.

Could a simple blood test reveal how well someone is aging?

In the news release, Fluid AI Medical Receives FDA 510(k) Clearance for Origin™, a Real-Time Postoperative Bedside Monitoring Device, issued 24-Sep-2025 by Fluid AI Medical over PR Newswire, we are advised by the company that the news release has been updated.